Literature DB >> 31865894

Cortical Microinfarcts Detected by 3-Tesla Magnetic Resonance Imaging: Differentiation Between Cerebral Amyloid Angiopathy and Embolism.

Hidehiro Ishikawa1, Yuichiro Ii1, Akihiro Shindo1, Ken-Ichi Tabei1,2, Maki Umino3, Ai Ogawa Ito1, Keita Matsuura1, Akira Taniguchi1, Hirofumi Matsuyama1, Atsushi Niwa1, Toru Ogura4, Kimiko Yoshimaru5, Masayuki Satoh5, Masayuki Maeda6, Hidekazu Tomimoto1.   

Abstract

Background and Purpose- Cortical microinfarcts (CMIs) are small ischemic lesions found in cerebral amyloid angiopathy (CAA) and embolic stroke. This study aimed to differentiate CMIs caused by CAA from those caused by microembolisms, using 3-Tesla magnetic resonance imaging. Methods- We retrospectively investigated 70 patients with at least 1 cortical infarct <10 mm on 3-dimensional double inversion recovery imaging. Of the 70 patients, 43 had an embolic stroke history (Emboli-G) while 27 had CAA-group. We compared the size, number, location, and distribution of CMIs between groups and designed a radiological score for differentiation based on the comparisons. Results- CAA-group showed significantly more lesions <5 mm, which were restricted to the cortex (P<0.01). Cortical lesion number was significantly higher in Emboli-G than in CAA-group (4 versus 2; P<0.01). Lesions in CAA-group and Emboli-G were disproportionately located in the occipital lobe (P<0.01) and frontal or parietal lobe (P=0.04), respectively. In radiological scoring, ≥3 points strongly predicted microembolism (sensitivity, 63%; specificity, 92%) or CAA (sensitivity, 63%; specificity, 91%). The areas under the receiver operating characteristic curve were 0.85 and 0.87 for microembolism and CAA, respectively. Conclusions- Characteristics of CMIs on 3T-magnetic resonance imaging may differentiate CMIs due to CAA from those due to microembolisms.

Entities:  

Keywords:  ROC curve; cerebral amyloid angiopathy; cerebral infarction; dementia; embolism; magnetic resonance imaging; stroke

Mesh:

Year:  2019        PMID: 31865894     DOI: 10.1161/STROKEAHA.119.028202

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  5 in total

1.  Evaluation of cortical superficial siderosis in patients with cognitive dysfunction using 3D FLAIR and 3D DIR.

Authors:  Maki Umino; Masayuki Maeda; Ryota Kogue; Satoshi Nakamura; Yuichiro Ii; Hidekazu Tomimoto; Hajime Sakuma
Journal:  Eur Radiol       Date:  2021-02-25       Impact factor: 5.315

2.  Micro-MRI improves the accuracy of clinical diagnosis in cerebral small vessel disease.

Authors:  Hidehiro Ishikawa; Atsushi Niwa; Shinya Kato; Yuichiro Ii; Akihiro Shindo; Keita Matsuura; Yamato Nishiguchi; Asako Tamura; Akira Taniguchi; Masayuki Maeda; Yoshio Hashizume; Hidekazu Tomimoto
Journal:  Brain Commun       Date:  2021-04-08

Review 3.  Clinical Features and Experimental Models of Cerebral Small Vessel Disease.

Authors:  Akihiro Shindo; Hidehiro Ishikawa; Yuichiro Ii; Atsushi Niwa; Hidekazu Tomimoto
Journal:  Front Aging Neurosci       Date:  2020-05-05       Impact factor: 5.750

Review 4.  Taxifolin: A Potential Therapeutic Agent for Cerebral Amyloid Angiopathy.

Authors:  Satoshi Saito; Masashi Tanaka; Noriko Satoh-Asahara; Roxana Octavia Carare; Masafumi Ihara
Journal:  Front Pharmacol       Date:  2021-02-12       Impact factor: 5.810

5.  Clinical features and imaging markers of small vessel disease in symptomatic acute subcortical cerebral microinfarcts.

Authors:  Wendan Tao; Yajun Cheng; Wen Guo; William Robert Kwapong; Chen Ye; Bo Wu; Shuting Zhang; Ming Liu
Journal:  BMC Neurol       Date:  2022-08-23       Impact factor: 2.903

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.